1,232
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Systolic and diastolic blood pressure, mean arterial pressure and pulse pressure for prediction of cardiovascular events and mortality in a Middle Eastern population

, , &
Pages 12-18 | Received 16 Feb 2011, Accepted 07 Apr 2011, Published online: 16 Jun 2011

References

  • Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371: 1513–1518.
  • Dorjgochoo T, Shu XO, Zhang X, Li H, Yang G, Gao L, . Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: A population-based prospective study. J Hypertens. 2009;27:468–475.
  • Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, . Hypertension: Its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens. 2007;25:73–79.
  • Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, . Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: Methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9:167.
  • Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. J Hypertens. 2006;24:423–430.
  • Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet. 2006; 367:1747–1757.
  • Mason PJ, Manson JE, Sesso HD, Albert CM, Chown MJ, Cook NR, . Blood pressure and risk of secondary cardiovascular events in women: The Women's Antioxidant Cardiovascular Study (WACS). Circulation. 2004;109: 1623–1629.
  • Mattace-Raso FU, van der Cammen TJ, van Popele NM, van der Kuip DA, Schalekamp MA, Hofman A, . Blood pressure components and cardiovascular events in older adults: The Rotterdam study. J Am Geriatr Soc. 2004;52: 1538–1542.
  • Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999; 100:354–360.
  • Assmann G, Cullen P, Evers T, Petzinna D, Schulte H. Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. Eur Heart J. 2005; 26:2120–2126.
  • Shara NM. Cardiovascular disease in Middle Eastern women. Nutr Metab Cardiovasc Dis. 2010;20:412–418.
  • Azizi F, Ghanbarian A., Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.
  • Pastor-Barriuso R, Banegas JR, Damian J, Appel LJ, Guallar E. Systolic blood pressure, diastolic blood pressure, and pulse pressure: An evaluation of their joint effect on mortality. Ann Intern Med. 2003;139:731–739.
  • Beevers DG. Epidemiological, pathophysiological and clinical significance of systolic, diastolic and pulse pressure. J Hum Hypertens. 2004;18:531–533.
  • Hilden T. The influence of arterial compliance on diastolic blood pressure and its relation to cardiovascular events. J Hum Hypertens. 1991;5:131–135.
  • Smulyan H, Safar ME. The diastolic blood pressure in systolic hypertension. Ann Intern Med. 2000;132:233–237.
  • Miura K, Dyer AR, Greenland P, Daviglus ML, Hill M, Liu K, . Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: The Chicago Heart Association Detection Project in Industry Study. Hypertension. 2001;38: 232–237.
  • Mosley WJ, 2nd, Greenland P, Garside DB, Lloyd-Jones DM. Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes. Hypertension. 2007; 49:1256–1264.
  • Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, . Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001;103:1245–1249.
  • Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, . Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757–764.
  • Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, . Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997;277:739–745.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.